[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Edwards Lifesciences Corp (EW)

Edwards Lifesciences (EW) sees mixed sentiment as Jim Cramer's short call clashes with positive analyst ratings and FDA approvals. Recent social posts highlight potential gains from following specific traders, while others focus on the company's innovation and investor day takeaways.

About Edwards Lifesciences Corp

Edwards Lifesciences Corp. is a medical device company specializing in heart valve and critical care technologies.
Edwards Lifesciences Corp uses the ticker $EW for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Edwards Lifesciences Corp (EW) market dominance near a 52-week low at XXXXXX.
Edwards Lifesciences Corp (EW) engagements near a 52-week low at XXX.
Edwards Lifesciences Corp (EW) trading volume is up XXXXX% from the previous week.
Edwards Lifesciences Corp (EW) creators is up XXXXX% from the previous month.
Edwards Lifesciences Corp Price hit a 52-Week high of $XXXXX for the hour

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The stock is experiencing a slight decline from its 52-week high, likely influenced by negative social media sentiment from Jim Cramer's short call, despite overall positive analyst ratings and FDA approvals. However, recent social posts suggest a potential for gains by following certain trading strategies, indicating a divided market sentiment.

24-Hour: XXXX% 7-Day: XXXX% 30-Day: -XXXX%

1-Year High: $XXXXX on 2025-11-25
1-Year Low: $XXXXX on 2025-04-08

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Edwards Lifesciences Corp (EW) is currently AltRank #971 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX +100
X Month: XXX +81
X Months: XXX +447
X Year: XXX +169
1-Year High: XXXXX on 2025-08-12
1-Year Low: XX on 2025-01-19

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-05-27
1-Year Low: XX on 2025-09-05

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX +4.10%
X Months: XXXXXXXXX +2.40%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-02-11
1-Year Low: XXX on 2025-10-12

Engagements by network (24h): Reddit: X X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +432%
X Months: XXXXX +43%
X Year: XXXXXX +29%
1-Year High: XXX on 2025-11-24
1-Year Low: XX on 2025-12-07

Mentions by network (24h): Reddit: X X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Edwards Lifesciences Corp (EW) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XXX +15%
X Month: XXX +20%
X Months: XXXXX +55%
X Year: XXXXX +32%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-12-07

The most influential creators that mention Edwards Lifesciences Corp in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@nataninvesting	X	XXXXXX	X	XXX
@BuyTheUgly	X	XX	X	XX
@BiopharmIQ	X	XXXXXX	X	XX
@Tickeron	X	XXXXXX	X	XX
@seedytx19	X	XXXXX	X	XX
@DRGinvests	X	XXXXX	X	XX
@Wallstreetle	X	XX	X	XX

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +14%
X Months: XXX% +31%
X Year: XXX% +47%
1-Year High: XXX% on 2025-01-26
1-Year Low: XX% on 2025-10-04

Most Supportive Themes:

FDA Approval and Earnings Growth: (30%) Edwards Lifesciences' recent FDA approval and strong first-quarter earnings are positively influencing investor sentiment and driving market confidence.
Analyst Upgrade: (25%) Citigroup's upgrade of Edwards Lifesciences to 'Buy' with a $XX price target has significantly boosted investor confidence and positive market outlook.
Investment Inclusion: (20%) The inclusion of Edwards Lifesciences in various investment portfolios and watchlists is increasing investor interest and market visibility.

Most Critical Themes:

Cramer's Short Call: (15%) Jim Cramer's recent short call on Edwards Lifesciences has introduced concerns among investors, contributing to negative sentiment despite other positive indicators.
Low Tax Markets: (10%) Concerns related to low tax markets have been identified as a contributing factor to negative sentiment surrounding Edwards Lifesciences.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
X Month: XXXX% +0.0078%
X Months: XXXX% +0.0063%
X Year: XXXX% -XXXXX%
1-Year High: XXXXX% on 2025-02-08
1-Year Low: XXXXXX% on 2025-10-12

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-11-23
1-Year Low: XXXXX% on 2025-12-11

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$2.60%
X Month: $XXXXXXXXXXXXXX -$1.10%
X Months: $XXXXXXXXXXXXXX +$11%
X Year: $XXXXXXXXXXXXXX +$13%
1-Year High: $XXXXXXXXXXXXXX on 2025-11-25
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08